$14.24 $0.94 per serving
Product analysis
Propolis Extract 2000 mg supplies propolis for immune support, but its unspecified preparation makes the amount of relevant plant compounds difficult to judge.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The propolis preparation is not identified clearly enough to compare quality. Its plant-compound content can vary with its origin and extraction.
Ingredient Transparency63
The propolis amount is stated for serving comparisons. The preparation is unspecified, so the amount alone does not identify its active-compound content.
Value For Money40
There is not enough information to judge the propolis contribution for value confidently. A generic extract amount does not support a clear comparison with a characterized preparation.
Customer Satisfaction88
Customer ratings are positive across a very large number of reviews. The volume provides a broad view of satisfaction.
Product Focus90
The single ingredient keeps the intended use focused on propolis and immune-related support. Findings for a standardized oral spray or selected health conditions do not establish routine benefits from this preparation.
- Format
Liquid - Container
- 1 Liquid(s)
- Per serving
- $0.94
- Customer rating
- 4.6 · 14,189 ratings
Goals
Impact
Highest effect
Propolis · 2000 mg
Propolis has been studied for earlier symptom relief during mild acute upper respiratory illness using a standardized oral spray. That local delivery and measured polyphenol exposure cannot be transferred to a generic extract amount or raw-equivalent claim. The supplied 2000 mg serving therefore does not establish routine systemic infection prevention, despite the favorable saved findings.
How this product is rated for Immunity
Ingredient fit97
Propolis supplies the focused ingredient finding, with its declared amount reaching the saved comparison endpoint. Clinical interpretation remains limited by preparation and delivery.
Goal fit
The relevant ingredient contribution gives this product a focused connection to immune support.
Dose adequacy
The relevant declared amounts reach the saved comparison endpoints; higher amounts do not establish greater immune benefit.
Pathways60
The strongest saved finding concerns protective barriers and antimicrobial defense. Substantial coverage is concentrated in this area.
Depth
The strongest saved finding concerns protective barriers and antimicrobial defense; it does not by itself establish fewer infections.
Breadth
Substantial coverage is concentrated in one immune area.
Evidence95
The favorable propolis finding exceeds what can be generalized from the supplied spray trial. Preparation, local delivery and acute symptom endpoints limit expectations.
Evidence strength
Propolis leads the saved finding, but the clinical evidence concerns a specific acute-treatment spray rather than generic systemic prevention.
Studied preparation
The saved preparation finding is favorable, but generic extract mass does not establish equivalence to the studied oral spray.
Formulation logic100
The relevant ingredients have the partners they require, no configured conflict was found, and included amounts meet the minimum saved comparison.
Partner coverage
Relevant ingredients can contribute independently or have their required partners present; an extra combination benefit is not established.
Conflicts
No configured conflict was identified among the supplied ingredients.
Effective doses
The included ingredients meet the saved minimum amount comparison; this does not establish proven clinical efficacy at those amounts.
Impact
Highest effect
Propolis · 2000 mg
Propolis supplies plant compounds with a connection to inflammatory signalling. Its composition varies with botanical origin and extraction, so propolis mass does not establish its active-compound content. Findings from selected disease groups and local oral applications do not establish routine systemic benefit from this particular preparation. The selected amount refers to one 2 mL serving.
How this product is rated for Inflammation
Ingredient fit97
Propolis carries the main relevant contribution. The selected amount is substantial within the saved comparison.
Goal fit
Propolis provides a focused connection to this goal, although the product is linked to other uses.
Dose adequacy
The selected serving supplies a substantial amount for the saved comparison, without proving a clinical effect.
Pathways59
The recorded contribution centers on inflammatory gene signalling. Other inflammatory processes have less coverage.
Depth
The strongest recorded connection is to inflammatory gene signalling, without establishing that these processes will change clinically.
Breadth
One main area carries the recorded contribution; support does not extend broadly across the other inflammatory processes.
Evidence96
Propolis leads the evidence findings, with important limits in the populations, markers or preparations studied.
Evidence strength
Propolis leads the saved evidence findings, but the supplied human results remain limited or context dependent.
Studied preparation
The saved findings recognize the contributing preparation; this does not establish that the selected serving reproduces the studied regimen.
Formulation logic100
The retained ingredients can contribute without a missing partner, and no configured conflict was found.
Partner coverage
The contributing ingredients do not require a missing partner in the saved findings.
Conflicts
No configured ingredient conflict was identified in the supplied calculation.
Effective doses
The ingredients retained as meaningful contributions clear the saved amount threshold; this is not proof of a clinical effect.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Propolis resin extract | 2000 mg |
Propolis · 2000 mg OverallScore57
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Propolis increases Foxp3 expression and lymphocyte proliferation in HIV-infected people: A randomized, double blind, parallel-group and placebo-controlled study.
- Immune Responses in Broiler Chicks Fed Propolis Extraction Residue-supplemented Diets.
- Integrative Therapies in Wound Healing in Small Animals: An Approach Beyond Traditional Medicine.
- Propolis does not significantly modulate immune function in an older population: A preliminary study.
- A standardized polyphenol mixture extracted from poplar-type propolis for remission of symptoms of uncomplicated upper respiratory tract infection (URTI): A monocentric, randomized, double-blind, placebo-controlled clinical trial.
- Effect of Propolis Intake on Serum C-Reactive Protein (CRP) and Tumor Necrosis Factor-alpha (TNF-α) Levels in Adults: A Systematic Review and Meta-Analysis of Clinical Trials.
- Propolis supplementation can reduce serum level of interleukin-6, C-reactive protein, and tumor necrosis factor-α: an updated systematic review and dose-response meta-analysis on randomized clinical trials.
- Effects of propolis supplementation on glycemic status, lipid profiles, inflammation and oxidative stress, liver enzymes, and body weight: a systematic review and meta-analysis of randomized controlled clinical trials.
- Brazilian organic propolis for prevention and treatment of radiation-related oral acute toxicities in head and neck cancer patients: A double-blind randomized clinical trial.
- The effect of Brazilian Green Propolis extract on inflammation in patients with chronic kidney disease on peritoneal dialysis: A randomised double-blind controlled clinical trial.